- Health Canada DPD: CLOPIXOL ACUPHASE (LUNDBECK CANADA INC, DIN 02230405) · product monograph (PDF)
- Health Canada DPD: CLOPIXOL DEPOT (LUNDBECK CANADA INC, DIN 02230406) · product monograph (PDF)
- Spain CIMA (Spanish): search for “zuclopentixol” (external search; text not reproduced)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Solution for injection: 50 mg/mL
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Zuclopenthixol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Clopixol- AcuphaseZuclopenthixol acetate | 50 mg/mL solution for Injection ( IM)USP Type I Borosilicate colorless glass ampoule Box of 5's x 1mL | RxVAT-exempt | H.Lundbeck A/SDenmark | Metro Drug, Inc. | DR-XY15245 | Jun 24, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .